By Daily Mail Reporter

PUBLISHED: 20:03 EST, 13 October 2012 | UPDATED: 20:15 EST, 13 October 2012

Soon even those of us who never go faster than the posted speed limit will have access to the same motion sickness drug that helps astronauts deal with the rigors of being launched into orbit.

NASA has signed a deal with a California's Epiomed Therapeutics to develop a nasal spray for motion sickness, based on a drug already administered to astronauts.

About half the astronauts who go into space develop motion sickness, with sumptoms including nausea and feeling light-headed.

Dizzy: NASA developed a drug to combat motion sickness after 40 percent of astronauts reported symptoms

To help give astronauts combat the effects, NASA has developed afast-acting drug called intransal scopolamine, or INSCOP.

INSCOP can be taken as a tablet, transdermal patch, or injected but the most reliable method of administering the drug is with a nasal spray.

'NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness,' said NASA researcher Lakshmi Putcha, with the Johnson Space Center in Houston.

Read more here:

NASA signs deal to make astronaut drug available to combat motion sickness